Generated August 15, 2026.
Overview
NVDY and ULTY are both weekly-distribution ETFs using synthetic covered call strategies to generate income from equity exposure. The key difference: NVDY tracks a single stock (NVIDIA), while ULTY rotates through a basket of high-volatility U.S. equities. NVDY offers concentrated leverage to NVIDIA's volatility at a 39.33% distribution rate; ULTY chases higher yields (60.33%) across multiple names, accepting basket-level concentration risk and active management.
How they differ
NVDY's defining feature is single-name exposure to NVIDIA via a synthetic covered call overlay, capping upside potential but converting that forgone gain into weekly income. ULTY spreads its call-writing across a rotating basket of volatile stocks, introducing active management decisions and timing risk around which names enter and exit the portfolio. The yield gap is substantial: ULTY distributes 60.33% annualized versus NVDY's 39.33%, but that higher payout reflects ULTY's shorter inception date (February 2024 versus May 2023) and the volatility-chasing mandate—higher realized volatility in the underlying basket fuels larger option premiums. ULTY also carries a marginally higher expense ratio (1.14% versus 1.01%) and has less than half NVDY's AUM ($759M versus $1.42B), suggesting less operational scale.
Who each is best for
NVDY: Investors who hold or want exposure to NVIDIA but are willing to cap upside in exchange for weekly income and lower volatility drag—suits those seeking a hedge-like structure around a core conviction.
ULTY: Income-focused investors comfortable with active basket rotation and prepared for higher interim volatility swings; designed for portfolios where capturing elevated premiums from changing volatility regimes across multiple names outweighs the simplicity of single-stock tracking.
Key risks to know
- NAV erosion at extreme distribution rates. Both funds distribute yields well above historical equity returns. ULTY's 60.33% rate is particularly aggressive; if underlying gains don't match distributions, NAV will erode over time. The shorter track record (ULTY launched in February 2024) means less proof of long-term sustainability.
- Capped upside from covered call overlay. Both strategies limit participation in rallies above the strike prices. In a sustained bull market for tech or the broader market, these ETFs will lag their underlying exposures by the amount of forgone appreciation.
- Concentration and basket-drift risk. NVDY is entirely dependent on NVIDIA's business and sentiment; any idiosyncratic shock to the stock hits hard. ULTY's active rotation means the basket composition changes, creating timing and overlap risk—the manager's stock picks may not align with peak volatility windows, reducing premium capture.
- Beta and leverage amplification. Both carry betas above 1.0 (NVDY at 1.36, ULTY at 1.3581), indicating leveraged or derivatives-driven amplification. In a sharp equity drawdown, these funds will decline faster than the broad market.
- Liquidity and tracking risk in options market. Weekly rebalancing and the synthetic overlay depend on deep, liquid options markets. Disruptions in options pricing or availability (rare but possible) could widen spreads or impair the fund's ability to execute its strategy.
Bottom line
NVDY offers concentrated conviction in NVIDIA with a moderate income yield and a nine-month operating history. ULTY chases a higher income stream across a rotating basket, but at the cost of active management opacity and a shorter track record. If you value simplicity and a proven underlying business, NVDY's single-name approach is more transparent; if you prioritize maximum current yield and accept active rebalancing, ULTY's higher distribution may appeal. Neither should be treated as a substitute for traditional equity exposure—both are income overlays that sacrifice capital appreciation potential. Past performance does not predict future results.
AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.